AC Immune
ACIU
ACIU
35 hedge funds and large institutions have $49.8M invested in AC Immune in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
13% less capital invested
Capital invested by funds: $57.2M → $49.8M (-$7.35M)
50% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 12
Holders
35
Holding in Top 10
–
Calls
$105K
Puts
$118K
Top Buyers
| 1 | +$310K | |
| 2 | +$182K | |
| 3 | +$130K | |
| 4 |
Renaissance Technologies
New York
|
+$79.8K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$10.4K |
Top Sellers
| 1 | -$1.94M | |
| 2 | -$200K | |
| 3 | -$127K | |
| 4 |
VEA
Virtus ETF Advisers
New York
|
-$124K |
| 5 |
Two Sigma Advisers
New York
|
-$95K |